Recurring and Emerging Ethical Issues in Pragmatic Clinical Trials.
作者信息
Propes Caleigh, O'Rourke P Pearl, Morain Stephanie R
机构信息
Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health and the Berman Institute of Bioethics, Baltimore, MD (C.P., S.R.M.). Dr O'Rourke is retired.
出版信息
Circ Cardiovasc Qual Outcomes. 2024 Jul;17(7):e010847. doi: 10.1161/CIRCOUTCOMES.124.010847. Epub 2024 Jul 16.
Abstract
摘要
相似文献
1
Recurring and Emerging Ethical Issues in Pragmatic Clinical Trials.
Circ Cardiovasc Qual Outcomes. 2024 Jul;17(7):e010847. doi: 10.1161/CIRCOUTCOMES.124.010847. Epub 2024 Jul 16.
2
Ethical Considerations in Conducting Pragmatic Trials in Oncology.
Oncol Nurs Forum. 2017 Sep 1;44(5):537-539. doi: 10.1188/17.ONF.537-539.
3
The ethical challenges raised in the design and conduct of pragmatic trials: an interview study with key stakeholders.
Trials. 2019 Dec 23;20(1):765. doi: 10.1186/s13063-019-3899-x.
4
Cluster over individual randomization: are study design choices appropriately justified? Review of a random sample of trials.
Clin Trials. 2020 Jun;17(3):253-263. doi: 10.1177/1740774519896799. Epub 2020 May 5.
5
Pragmatic randomized trials in drug development pose new ethical questions: a systematic review.
Drug Discov Today. 2015 Jul;20(7):856-62. doi: 10.1016/j.drudis.2015.03.005. Epub 2015 Mar 17.
6
Ethical Acceptability of Postrandomization Consent in Pragmatic Clinical Trials.
JAMA Netw Open. 2018 Dec 7;1(8):e186149. doi: 10.1001/jamanetworkopen.2018.6149.
7
Are pragmatism and ethical protections in clinical trials a zero-sum game?
Clin Trials. 2025 Feb;22(1):109-115. doi: 10.1177/17407745241284798. Epub 2024 Oct 15.
8
Stakeholders' views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs.
Trials. 2016 Aug 22;17(1):419. doi: 10.1186/s13063-016-1546-3.
9
Ethical considerations for sharing aggregate results from pragmatic clinical trials.
Clin Trials. 2025 Apr;22(2):248-254. doi: 10.1177/17407745241290782. Epub 2024 Nov 25.
10
引用本文的文献
1
Landscape of informed consent practices and challenges in point-of-care clinical trials.
Learn Health Syst. 2025 Mar 3;9(3):e10467. doi: 10.1002/lrh2.10467. eCollection 2025 Jul.
本文引用的文献
1
Equity and bias in electronic health records data.
Contemp Clin Trials. 2023 Jul;130:107238. doi: 10.1016/j.cct.2023.107238. Epub 2023 May 22.
2
Health equity considerations in pragmatic trials in Alzheimer's and dementia disease: Results from a methodological review.
Alzheimers Dement (Amst). 2023 Feb 5;15(1):e12392. doi: 10.1002/dad2.12392. eCollection 2023 Jan-Mar.
3
Benefits of Streamlined Point-of-Care Trial Designs: Lessons Learned From the UK RECOVERY Study.
JAMA Intern Med. 2022 Dec 1;182(12):1243-1244. doi: 10.1001/jamainternmed.2022.4810.
4
Toward Meeting the Obligation of Respect for Persons in Pragmatic Clinical Trials.
Hastings Cent Rep. 2022 May;52(3):9-17. doi: 10.1002/hast.1391.
5
Think Pragmatically: Investigators' Obligations to Patient-Subjects When Research is Embedded in Care.
Am J Bioeth. 2023 Aug;23(8):10-21. doi: 10.1080/15265161.2022.2063435. Epub 2022 Apr 18.
6
Identification and management of pragmatic clinical trial collateral findings: A current understanding and directions for future research.
Healthc (Amst). 2021 Dec;9(4):100586. doi: 10.1016/j.hjdsi.2021.100586. Epub 2021 Sep 29.
7
Improving the enrollment of women and racially/ethnically diverse populations in cardiovascular clinical trials: An ASPC practice statement.
Am J Prev Cardiol. 2021 Aug 20;8:100250. doi: 10.1016/j.ajpc.2021.100250. eCollection 2021 Dec.
8
Ethics and Collateral Findings in Pragmatic Clinical Trials.
Am J Bioeth. 2020 Jan;20(1):6-18. doi: 10.1080/15265161.2020.1689031.
9
Ethics and regulatory complexities for pragmatic clinical trials.
JAMA. 2014 Jun 18;311(23):2381-2. doi: 10.1001/jama.2014.4164.
Zotero 插件